RECRO PHARMA INC
(75629F109)
Fondsberichterstattung Bestände von RECRO PHARMA INC gemäß 13F Anmeldungen
| Firmenname | Gehaltene Aktien / Nennbetrag | Marktwert | Möglichkeit | Berichtszeitraum | Gültigkeitsdatum |
|---|---|---|---|---|---|
| Broadfin Capital LLC | 1,561,617 | $15,882k | Jun 30, 2019 | Aug 14, 2019 | |
| Corsair Capital Management LP | 742,900 | $7,555k | Jun 30, 2019 | Aug 13, 2019 | |
| North RUN Capital LP | 315,338 | $3,207k | Jun 30, 2019 | Aug 14, 2019 | |
| Acadian Asset Management LLC | 258,740 | $2,631k | Jun 30, 2019 | Aug 8, 2019 | |
| Brandywine Global Investment Management LLC | 140,000 | $1,424k | Jun 30, 2019 | Aug 14, 2019 | |
| Fondren Management LP | 95,000 | $966k | Jun 30, 2019 | Aug 14, 2019 | |
| Monarch Partners Asset Management LLC | 77,687 | $790k | Jun 30, 2019 | Aug 8, 2019 | |
| Spark Investment Management LLC | 70,700 | $719k | Jun 30, 2019 | Aug 12, 2019 | |
| Dupont Capital Management Corp | 55,394 | $563k | Jun 30, 2019 | Jul 30, 2019 | |
| Campbell & Company Investment Adviser LLC | 38,989 | $397k | Jun 30, 2019 | Jul 10, 2019 | |
| Prelude Capital Management LLC | 337 | $3k | Jun 30, 2019 | Aug 14, 2019 |